Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | 0.00% | +0.59% | +1.80% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 13.5M | Capitalization | 107M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -82M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.9 x |
P/E ratio 2024 * |
-1.48
x | P/E ratio 2025 * |
-1.1
x | Employees | 47 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.37% |
Latest transcript on Milestone Pharmaceuticals Inc.
1 week | +0.59% | ||
Current month | +3.03% | ||
1 month | +0.29% | ||
3 months | +6.25% | ||
6 months | -41.58% | ||
Current year | +1.80% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 17-03-06 |
Amit Hasija
DFI | Director of Finance/CFO | 51 | 19-09-08 |
Anita Holz
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Seth Fischer
BRD | Director/Board Member | 68 | 23-03-20 |
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 17-03-06 |
Debra Liebert
BRD | Director/Board Member | 67 | 15-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.7 | 0.00% | 36,354 |
24-05-09 | 1.7 | 0.00% | 21,117 |
24-05-08 | 1.7 | -2.30% | 250,457 |
24-05-07 | 1.74 | 0.00% | 148,259 |
24-05-06 | 1.74 | +2.96% | 297,133 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.80% | 107M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MIST Stock